Every finding on record at Gericare, LLC

An Emergency Preparedness recertification and re-licensure survey was conducted on 5/4/2026 - 5/5/2026. The facility meets all of the requirements for Emergency Preparedness. There were no deficiencies identified.

A recertification survey was conducted on 5/4/2026-5/5/2026 An entrance conference was held on 5/4/2026 at 8:15 AM, with the Executive Director. An exit conference was held on 5/5/2026 at 4:15 PM, with the agencies administration.

A review of all current medications CFR(s): 484.55(c)(5) A review of all medications the patient is currently using in order to identify any potential adverse effects and drug reactions, including ineffective drug therapy, significant side effects, significant drug interactions, duplicate drug therapy, and noncompliance with drug therapy. This ELEMENT is not met as evidenced by: Based on policy review, medical record review, and interview, the agency failed to update the medication profile for 3 of 3 (Patient #1, #2, and #3) sampled patients observed during home visits. The findings included: 1.Review of the agency’s “Monitoring Medications” policy dated 4/1/2026, revealed “…A drug regimen review will be performed on all patients in conjunction with all comprehensive assessments. Additionally, all clinicians will participate in medication review and reconciliation throughout the episode…” 2.Medical record review for Patient #1 revealed a start of care date of 2/19/2026, with diagnoses of Orthopedic Aftercare following Surgical Amputation, Diabetes Mellitus, Hypertension, and Obesity. Observations in Patient #1's home on 5/4/2026 at 2:45 PM, revealed the following medications in the home: 3/13/2026 Potassium Chloride (supplement) 10 milliequivalents (mEq) orally every day 3/13/2026 Ezetimibe (treats high cholesterol) 10 milligram (mg) orally every day 3/23/2026 Amlodipine (treats high blood pressure) 5 mg orally every day During an interview on 5/4/2026 at 3:10 PM, Patient #1 confirmed she takes Potassium Chloride, Ezetimibe, and Amlodipine. 3.Medical record review for Patient #2 revealed a start of care date of 2/24/2026, with diagnoses of Stage 2 Sacral Pressure Ulcer, Hypertensive Heart and Chronic Kidney Disease, Diabetes Mellitus, and Atrial Fibrillation. Review of the Home Health Certification and Plan of Care for certification period of 4/25/2026 to 6/23/2026, revealed “...Fluticasone Propionate [respiratory therapy] 50 mcg [micrograms]…nasal suspension…1 spray 2 times daily...” During an interview on 5/5/2026 at 9:20 AM, Patient #2 confirmed he has not used the Fluticasone; it was discontinued. 4. Medical record review for Patient #3 revealed a start of care date of 2/5/2026, with diagnoses of Hypertensive Heart and Chronic Kidney Disease with Heart Failure, Diabetes Mellitus, Myocardial Infarction, and History of Malignant Neoplasm of Prostate. Review of Patient #3’s home medications revealed Torsemide (treats edema) 20 mg orally every day as needed. During an interview on 5/5/2026 at 9:30 AM, Patient #3 confirmed he occasionally uses Torsemide for lower leg swelling. During an interview on 5/5/2026 at 1:59 PM, the Executive Director confirmed medication reconciliation was necessary.

An Emergency Preparedness recertification and re-licensure survey was conducted on 7/24/2023-7/25/2023. The facility meets all of the requirements for Emergency Preparedness. There were no deficiencies identified.

A recertification survey was conducted on 7/24/2023-7/25/2023. An entrance conference was held on 7/4/2023 at 8:00 AM, with the Clinical Director. An exit conference was held on 7/25/2023 at 3:15 PM, with the agencies administration.

A review of all current medications CFR(s): 484.55(c)(5) A review of all medications the patient is currently using in order to identify any potential adverse effects and drug reactions, including ineffective drug therapy, significant side effects, significant drug interactions, duplicate drug therapy, and noncompliance with drug therapy. This ELEMENT is not met as evidenced by: Based on policy review, medical record review, and interview, the agency failed to update the medication profile for 2 of 4 (Patient #2 and #3) patients reviewed. The findings included: Review of the agencies "Monitoring Medications," last revised 5/1/2019, revealed "...PURPOSE: To provide a process to ensure continuous monitoring of medications in the patient's home...POLICY: A drug regimen review will be performed on all patients in conjunction with all comprehensive assessments. Additionally, all clinicians will participate in medication review and reconciliation throughout the episode. For patients receiving skilled nursing and therapy services, the skilled nurse is responsible for medication review and reconciliation throughout the episode...For patients receiving only therapy services, the therapist is responsible to facilitate drug regimen review and medication reconciliation throughout the episode. One therapy discipline will hold the primary responsibility for medication reconciliation..." Review of the medical record revealed Patient #2 was admitted to the agency on 12/16/2022, with diagnoses of Diabetes Mellitus, Chronic Non-Pressure Ulcer of Left Ankle, Gout, and History of Falling. Review of the Home Health Certification and Plan of Care dated 6/1/2023 to 8/12/2023, revealed "...12/30/2022...Acidophilus Capsule [probiotic]...2 times daily...oral...12/16/2022...Advil [analgesic] 200 mg [milligram]...as needed/prn [as needed]...oral...12/16/2023...Metformin [antihyperglycemic] 500 mg...daily...oral...12/16/2022...Protonix [treats Gastroesophageal Reflux] 40 mg...daily...oral...12/30/2022...Vitamin C supplement] 500 mg...2 times daily...oral...12/16/2022...Zyrtec 10 mg...daily...oral..." Review of Patient #2's home medications revealed "...Over the Counter [OTC] Vitality Multivitamin and Mineral...OTC Generic Tylenol 500 mg as needed..." During an interview with Licensed Practical Nurse [LPN] #1 on 7/25/2023 at 10:25 AM, she stated "...I'm going to remove the Protonix since it is the same thing as Pantoprazole...I don't see the daily Zyrtec either...I will add the Tylenol to her medication list..." She was asked if Patient #2's medications had been reconciled. She stated "No." During an interview with Patient #2 on 7/25/2023 at 10:35 AM, Patient #2 stated "...I don't take it [Metformin]...I don't take it all the time [Vitamin C] ..." Review of the medical record revealed Patient #3 was admitted to the agency on 3/2/2023 with diagnoses of Atherosclerotic Heart Disease, Peripheral Vascular Disease, Sick Sinus Rhythm, Personal History of Trans ischemic Attack and Cerebral Infarction, and History of Falling. Review of the Home Health Certification and Plan of Care dated 6/30/2023 to 8/28/2023, revealed "...3/2/2023...Fish Oil 1,200 mg... daily...oral...3/2/2023...Plavix [anticoagulant] 75 mg...3 times a week...oral..." Review of Patient #3's home medications revealed "...5/31/2022...Tamsulosin [treats Urinary Retention] 0.4 mg (2 capsules) ...oral...daily...5/22/2023...Sotalol [antiarrhythmic] ...80 mg... oral...twice daily...Metamucil [fiber supplement] ...1 spoon full in water...every day..." Interview with the caregiver on 7/25/2023 at 2:20 PM, she stated "...Doesn't take the Fish Oil anymore. He can't hardly swallow it...He takes Metamucil when he wants it..."

Discharge and transfer summaries CFR(s): 484.110(a)(6)(i-iii) (i) A completed discharge summary that is sent to the primary care practitioner or other health care professional who will be responsible for providing care and services to the patient after discharge from the HHA (if any) within 5 business days of the patient's discharge; or (ii) A completed transfer summary that is sent within 2 business days of a planned transfer, if the patient's care will be immediately continued in a health care facility; or (iii) A completed transfer summary that is sent within 2 business days of becoming aware of an unplanned transfer, if the patient is still receiving care in a health care facility at the time when the HHA becomes aware of the transfer. This ELEMENT is not met as evidenced by: Based on policy review, medical record review, and interview, the facility failed to provide the primary care physician a completed transfer summary when becoming aware of an unplanned transfer for 2 of 3 (Patient #8 and #10) discharged patients reviewed. The findings include: Review of the agency's "Patient Discharge/Transfer Process," policy dated 4/1/2023, revealed "...To ensure continuity of care when a patient is discharged, transferred, or referred...Any of the following reasons may be criteria for patient discharge or transfer...Patient refuses services or elects to be transferred or discharged...Patient dies..." Review of the medical record revealed Patient #9 was admitted to the agency on 4/25/2023 with diagnoses of Malignant Neoplasm of the Bronchus or Lung, Hypertension, Anxiety, and Sepsis. Review of the Visit Note Report dated 5/16/2023, revealed "...ER [emergency room] on 5/15/2023 due to Hemoptysis. Patient expired in the hospital..." Review of the medical record revealed Patient #10 was admitted to the agency on 4/6/2023 with diagnoses of End Stage Renal Disease and dependence on Renal Dialysis. Review of the Visit Note Report dated 5/8/2023, revealed "...Went to the hospital for SOB [shortness of breath] and coughing per wife...She states she is unable to take care of him anymore because of her health issues..." During an interview with the Performance Improvement Director on 7/24/2023 at 11:30 AM, she stated "...Both physicians were notified, but the transfer summary was not completed or sent to the physician unfortunately and there were supposed to have been..."